欧普康视盐酸毛果芸香碱滴眼液临床试验获批

Core Viewpoint - The company, Opcon Vision (300595), has received approval from the National Medical Products Administration for clinical trials of its drug, "Pilocarpine Eye Drops" [1] Group 1: Company Developments - Opcon Vision announced the receipt of a clinical trial approval notice for "Pilocarpine Eye Drops" [1] - The drug is an M-cholinergic receptor agonist that activates smooth muscles, specifically the iris sphincter and ciliary muscle [1] Group 2: Product Details - Pilocarpine works by contracting the iris sphincter to reduce pupil size, which increases depth of focus and improves near and intermediate vision [1] - The drug also contracts the ciliary muscle, enhancing accommodation, thereby treating presbyopia in adults [1]